Dr. Sharif Khan, MD
Claim this profileSaint Francis Hospital / Bon Secours - South Carolina
Affiliated Hospitals
Saint Francis Hospital / Bon Secours - South Carolina
Saint Francis Hospital
Clinical Trials Sharif Khan, MD is currently running
GFH009
for Blood Cancer
SLS009 (formerly GFH009) is a potent and highly selective CDK9 inhibitor. In this study the safety, tolerability, and antitumor activity of single agent SLS009 are assessed in two dose escalation groups (Group 1 in patients with relapsed/refractory AML, Group 2 in patients with relapse/refractory lymphoma/CLL/SLL). The safety, tolerability, and antitumor activity of SLS009 in combination with venetoclax and azacitidine in patient with relapsed/refractory AML who have relapsed on or are refractory to venetoclax-based regimens are being assessed in five cohorts of the expansion Group 3.
Recruiting
1 award
Phase 1 & 2
7 criteria
SEA-CD70
for Myelodysplastic Syndrome and Acute Myeloid Leukemia
This trial is testing a new drug, SEA-CD70, alone and with azacitidine, to see if it is safe and works for adults with certain blood cancers that haven't responded to other treatments. The study will determine the best dose and check for side effects. Azacitidine is a treatment that improves survival, reduces the need for transfusions, and lowers the risk of progression to acute myeloid leukemia in patients with higher risk myelodysplastic syndromes.
Recruiting
1 award
Phase 1
10 criteria
More about Sharif Khan, MD
Clinical Trial Related
6 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Sharif Khan, MD has experience with
- SEA-CD70
- Autologous Bone Marrow Transplantation
- Autologous Hematopoietic Stem Cell Transplantation
- Ibrutinib
- Daratumumab/rHuPH20
- Lenalidomide
Breakdown of trials Sharif Khan, MD has run
Acute Myelogenous Leukemia
Myelodysplastic Syndrome
Acute Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sharif Khan, MD specialize in?
Sharif Khan, MD focuses on Acute Myelogenous Leukemia and Lymphoma. In particular, much of their work with Acute Myelogenous Leukemia has involved treating patients, or patients who are undergoing treatment.
Is Sharif Khan, MD currently recruiting for clinical trials?
Yes, Sharif Khan, MD is currently recruiting for 2 clinical trials in Greenville South Carolina. If you're interested in participating, you should apply.
Are there any treatments that Sharif Khan, MD has studied deeply?
Yes, Sharif Khan, MD has studied treatments such as SEA-CD70, Autologous Bone Marrow Transplantation, Autologous Hematopoietic Stem Cell Transplantation.
What is the best way to schedule an appointment with Sharif Khan, MD?
Apply for one of the trials that Sharif Khan, MD is conducting.
What is the office address of Sharif Khan, MD?
The office of Sharif Khan, MD is located at: Saint Francis Hospital / Bon Secours - South Carolina, Greenville, South Carolina 29607 United States. This is the address for their practice at the Saint Francis Hospital / Bon Secours - South Carolina.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.